Physician profile
Daniel C Longo
NPI 1376510677
$6,375.97
in general payments reported to CMS, 2019-2025
38 companies · $1,833 in 2025
The $1,833 reported for 2025 was more than what 89% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $689 · 2020: $59.87 · 2021: $873 · 2022: $969 · 2023: $1,000 · 2024: $952 · 2025: $1,833.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,784.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,784.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,710.23 | 2019-2025 | Dart-Fire, Ortholoc 3di Crosscheck, Citrefix |
| Treace Medical Concepts, INC. | $1,004.06 | 2022-2025 | |
| Organogenesis INC. | $589.25 | 2019-2025 | Puraply Antimicrobial, Puraply, Affinity |
| Acadia Pharmaceuticals INC | $484.32 | 2021 | |
| Smith+Nephew, INC. | $445.65 | 2019-2025 | Grafix Pl, Collagenase Santyl, Regranex |
| Medtronic, INC. | $260.56 | 2022-2024 | Hawkone, In.Pact Av |
| Depuy Synthes Sales INC. | $242.61 | 2019-2023 | Hammerlock |
| Abbvie INC. | $157.39 | 2021-2023 | |
| Heron Therapeutics, INC. | $156.52 | 2021-2022 | |
| Horizon Therapeutics Plc | $125.52 | 2019-2021 | |
| Paratek Pharmaceuticals, INC. | $117.50 | 2021-2025 | Nuzyra |
| Seapearl East, INC | $113.42 | 2023 | |
| Medline Industries Lp | $112.18 | 2024 | |
| Trilliant Surgical LLC. | $76.21 | 2023 | Arsenal Ankle 10 Hole 1/3 Tubular Plate |
| Kerecis Limited | $76.15 | 2021-2025 | Kerecis Surgiclose, Kerecis Graftguide |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dynasplint Systems INC. | $62.29 | 2022 | |
| Bone Support INC. | $58.64 | 2025 | Ceramentbone Void Filler, Cerament G |
| Advanced Oxygen Therapy INC. | $53.06 | 2023-2024 | Topical Oxygen Chamber For Extremities, Topical Oxygen Chamber For Extremities |
| Reprise Biomedical, INC. | $48.65 | 2024-2025 | Miro3d |
| Next Science LLC | $45.92 | 2023 | Surgx, Blastx, Xperience |
| Djo, LLC | $45.16 | 2025 | Cmf |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $43.01 | 2024-2025 | Jublia |
| Bioventus LLC | $36.96 | 2023 | Sonicone Clinic |
| Biocomposites INC | $31.57 | 2025 | Stimulan |
| Kci USA, INC. | $30.04 | 2019-2022 | |
| Solventum Corporation | $25.76 | 2024 | Activ.A.C., V.A.C. Dermatac, Promogran Prisma |
| Misonix INC | $25.07 | 2019 | |
| Merck Sharp & Dohme LLC | $24.33 | 2019 | |
| Mimedx Group, INC. | $23.16 | 2025 | |
| Crossroads Extremity Systems, LLC | $21.47 | 2019 | |
| Paragon 28, INC. | $20.25 | 2019 | |
| Averitas Pharma INC. | $18.16 | 2025 | Qutenza |
| Melinta Therapeutics, LLC | $16.49 | 2019 | |
| Integra Lifesciences Corporation | $16.22 | 2020 | |
| Pfizer INC. | $16.20 | 2019 | |
| Grt US Holding, INC. | $14.31 | 2022 | |
| Ani Pharmaceuticals, INC. | $14.28 | 2025 | Purified Cortrophin Gel |
| Ibsa Pharma INC. | $13.40 | 2024 | Licart, Tirosint |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Longo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.